Targeted Agents in Gynecologic Cancers
Obstetrics & Gynecology International Journal · 2014
DOI: 10.15406/ogij.2014.01.00006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obstetrics & Gynecology International Journal, 2014. Verfasst von Emre Ozgu. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
and recurrences they loss their strength because of new mutation formation in the neoplastic tissue and other known/unknown processes of tumor cells.Recently new pathways for blocking tumor growth and dissemination are under research.Targeted therapy for tumor cells is one of these new approaches with direct and indirect methods.Despite chemotherapy affects rapidly dividing cells and may give suppression to gastrointestinal, myeloid system cells and hair growth, targeted therapies have a critical role on tumor growth, progression, invasion and metastasis by tumor cell selective therapy with less toxicity.Direct method can be briefly defined as altering tumor antigen signaling either by monoclonal antibodies (MoAbs) or by small molecule drugs on basis of target proteins.On the other hand, indirect method is against tumor antigens expressed on cell surface that is knotted by ligands.
Zitieren
APA
Ozgu, E. (2014). Targeted Agents in Gynecologic Cancers. Obstetrics & Gynecology International Journal. https://doi.org/10.15406/ogij.2014.01.00006
Vancouver
Ozgu E. Targeted Agents in Gynecologic Cancers. Obstetrics & Gynecology International Journal. 2014. doi:10.15406/ogij.2014.01.00006
BibTeX
@article{Ozgu2014,
author = {Ozgu, Emre},
title = {Targeted Agents in Gynecologic Cancers},
journal = {Obstetrics & Gynecology International Journal},
year = {2014},
doi = {10.15406/ogij.2014.01.00006}
}
EUVIMED